Video
Author(s):
“There was a point when people thought a trial [would] not be necessary because the answers [were] so clear cut. But obviously, more than just 1 person feels that these are not so clear-cut answers,” says Badar M. Mian, MD, FACS.
In this video, Badar M. Mian, MD, FACS, discusses what is to come for transperineal biopsy in regard to integrating this modality into the current standard of care for patients with prostate cancer. Mian is a professor of surgery and urology at Albany Med Urology in Albany, New York.